102460.KS
REYON Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 9,910.00
−0.40%Margins
Gross margin
21.5%
EBITDA margin
-10.5%
EBIT margin
-21.0%
Net margin
-24.0%
FCF margin
0.6%
-17.7%
Return on equity
-7.7%
Return on assets
-7.3%
Return on invested capital
0.32x
Asset turnover
KRW 6.0B
Cash from operations
KRW 379
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026